Posted by Michael Wonder on 23 Feb 2022
FDA approves nalmefene hydrochloride 2 mg/2 mL injection for the treatment of known or suspected opioid overdose with natural or synthetic opioids
23 February 2022 - Purdue Pharma announced today that FDA has approved its abbreviated new drug application for nalmefene hydrochloride 2 mg/2 mL injection.
The Company will be distributing injectable nalmefene for no profit.
